why choose us

First received: October 27, 2022

Clinical Trial: A Trial to Learn if Single Ascending Intravenous (IV) Doses of REGN7508 Are Safe and Well Tolerated, and How it Works in the Body of Healthy Adult Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Volunteer

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of REGN7508, a Monoc

Brief Summary: This study is researching an experimental drug called REGN7508 (called "study drug").The aim of this study is to see how safe and tolerable the study drug is in healthy participants.This study is looking at several other research questions, including:What side effects may happen from taking the study drugHow much study drug is in the blood at different timesWhether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)

Read more